Press release
Ocimum Biosolutions offers new solutions in microRNA microarray technology
The epoxide coated microarray slides are spotted with probes which target the miRNAs available in the latest (April 2010) mirBase Release 15 as well as many putative miRNAs. Apart from miRNA microarray chips, Ocimum also offers a complete range of customized services, from miRNA probe/chip design to suit specific experiments to end-to-end chip-to-analysis services.
Ms. Anu Acharya, CEO of Ocimum Biosolutions said “We have been offering the entire gamut of services – miRNA probe design, array design, spotting/printing, isolation, hybridization and bioinformatic analysis – for many years now. With this launch, we have bundled relevant services into a package making it even easier for researchers to work with us.”
She further added “With multiple arrays per slide, researchers will be able to perform multiple hybridization experiments per slide, making the OciChip™ miRNA kits very cost-effective compared to other providers.”
About miRNA Microarrays
miRNAs are small non-protein-coding RNA molecules that play a crucial role in development and life cycle of humans, animals and plants. They function as global regulators of gene expression by targeting specific mRNAs and play a significant role in disease manifestation. miRNAs either inhibit translation or promote mRNA degradation. miRNAs can also be hybridized to microarrays, slides or chips with probes to hundreds or thousands of miRNA targets, so that relative levels of miRNAs can be determined in different samples.
For more information, please visit www.ocimumbio.com.
For queries related to this press release, please write to vinay.k@ocimumbio.com.
About Ocimum Biosolutions
Ocimum Biosolutions is a global integrated genomic services company with operations in Hyderabad, India and Gaithersburg, MD (Gene Logic). We provide comprehensive (research level and GLP-compliant) genomic services, reference databases, and LIMS solutions. Our distinct platform "Research as a Service" (RaaS) allows complete outsourcing of genomics – from storing biological samples and performing on demand DNA and RNA based services to validating biomarkers using our proprietary databases and providing data and bioinformatic analysis. We have been chosen as a global preferred outsourcing provider for more than 75% of top 25 pharma and biotech companies plus leading research institutes. Our partners recognize our expertise for understanding disease mechanisms in correlation with discovery, prioritization of gene targets and biomarkers, and sample analysis for clinical studies
Dhanya menon
Communication manager
ocimum Biosolutions
6th floor,Road No 1, Banjara Hills
Hyderabad, Andhra Pradesh 500034
India
Phone :040 66986700
email: dhanya.m@ocimumbio.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ocimum Biosolutions offers new solutions in microRNA microarray technology here
News-ID: 137514 • Views: …
More Releases from Ocimum Biosolutions
Sciantis™ – Ocimum Biosolutions unveils its new software product to handle B …
cimum Biosolutions announces release of its new software product, Sciantis™, a lab process and data management platform for biologics labs. Sciantis™ helps Labs to manage Biologics development process, automate data capturing and support lab Analytics needs.
Mr. Subash Lingareddy, CFO, President of Ocimum Biosolutions, said, “Sciantis™ is our new software offering to serve Biologics companies in improving their development process and data management. This software also serves…
Ocimum Biosolutions Is Winner of Bioexcellence Award ( Bioinformatics and System …
Hyderabad, Andhra Pradesh, India, February 07th, 2012: The Jury of Industry experts constituted by ABLE has declared Ocimum Biosolutions as a Bioexcellence Award winner at Bio INDIA BIO 2012 event under Bioinformatics & Systems Biology Category.
Ms. Anuradha Acharya, CEO of Ocimum Biosolutions said, “Systems Biology and Bioinformatics will be the backbone of future therapeutics and diagnostics. At Ocimum we are focusing our efforts in these areas to meet the needs of the…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
